In a groundbreaking development, Moderna has received FDA approval for its cutting-edge COVID-19 vaccine, paving the way for its release in the upcoming 2025–2026 respiratory virus season. This milestone comes in the wake of the FDA’s introduction of a new approval framework for COVID-19 vaccines, signaling a new era in vaccine regulation. The announcement also […]
Tag: vaccines
Impact of COVID-19 on Biotechs in Vaccine Development
The current uncertain landscape surrounding COVID-19 vaccines has led to major challenges for biotech companies. With reductions in funding for research and potential disruptions in the industry, experts like Cheng Li from Oppenheimer warn of long-term consequences on the development of breakthrough therapies. The shift of investments away from basic research towards more profitable areas […]
Trump Cancels $766 Million Moderna Bird Flu Vaccine Deal
In a surprising move, President Trump has decided to scrap the $766 million deal with Moderna for a bird flu vaccine. Health Secretary Robert F. Kennedy, a vocal vaccine skeptic, has raised concerns about the safety of mRNA vaccines, despite their proven efficacy in saving lives. Moderna recently withdrew its application for a hybrid covid-flu […]
FDA Approves Next-Generation Covid Vaccine with Restrictions
In a recent development, the FDA has granted approval for a next-generation Covid vaccine from Moderna, albeit with certain restrictions in place. The approval letter mandates Moderna to conduct a new randomized controlled trial targeting adults aged 50 to 64, to ascertain the ongoing efficacy of Covid vaccination in this age group. Furthermore, a commentary […]